Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × SCLC × atezolizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 30 Carcinoma, Non-Small-Cell Lung 15 Small Cell Lung Carcinoma 11 Lung Neoplasms 11 Neoplasms 10 Breast Neoplasms 7 Liver Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Prostatic Neoplasms 4 Melanoma 4 Head and Neck Neoplasms 4 Sarcoma 3 Recurrence 3 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Carcinoma, Transitional Cell 3 Advanced Solid Tumor 3 Urogenital Neoplasms 2 Small Cell Lung Cancer Extensive Stage 2 Sarcoma, Alveolar Soft Part 2 Ovarian Neoplasms 2 Osteosarcoma 2 Neoplasms by Site 2 Neoplasms by Histologic Type 2 Liver Diseases 2 Hematologic Neoplasms 2 Glioblastoma 2

Interventions

atezolizumab 1 apatinib 1 Topotecan 1 Paclitaxel 1 Immune Checkpoint Inhibitors 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06179069 2025-08-15

A Study of ZL-1310 in Subjects With Small Cell Lung Cancer

Zai Lab (Hong Kong), Ltd.

Phase 1 Recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡